{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T12:40:27Z","timestamp":1791722427044,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1038\/s41589-023-01393-4","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T12:04:50Z","timestamp":1691064290000},"page":"162-169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Structural insight into selectivity of amylin and calcitonin receptor agonists"],"prefix":"10.1038","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9160-0228","authenticated-orcid":false,"given":"Jianjun","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Belousoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot","family":"Gerrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6406-8993","authenticated-orcid":false,"given":"Radostin","family":"Danev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine M.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Dal Maso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2249-2782","authenticated-orcid":false,"given":"Herman","family":"Schreuder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Evers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Besenius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4563-1642","authenticated-orcid":false,"given":"Denise","family":"Wootten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8902-2473","authenticated-orcid":false,"given":"Patrick M.","family":"Sexton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,3]]},"reference":[{"key":"1393_CR1","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/bcpt.13427","volume":"127","author":"HL Zakariassen","year":"2020","unstructured":"Zakariassen, H. L., John, L. M. & Lutz, T. A. Central control of energy balance by amylin and calcitonin receptor agonists and their potential for treatment of metabolic diseases. Basic Clin. Pharmacol. Toxicol. 127, 163\u2013177 (2020).","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"1393_CR2","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1124\/pr.115.010629","volume":"67","author":"DL Hay","year":"2015","unstructured":"Hay, D. L., Chen, S., Lutz, T. A., Parkes, D. G. & Roth, J. D. Amylin: pharmacology, physiology, and clinical potential. Pharm. Rev. 67, 564\u2013600 (2015).","journal-title":"Pharm. Rev."},{"key":"1393_CR3","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1517\/14656566.2011.581663","volume":"12","author":"LM Younk","year":"2011","unstructured":"Younk, L. M., Mikeladze, M. & Davis, S. N. Pramlintide and the treatment of diabetes: a review of the data since its introduction. Expert Opin. Pharmacother. 12, 1439\u20131451 (2011).","journal-title":"Expert Opin. Pharmacother."},{"key":"1393_CR4","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s00018-011-0905-1","volume":"69","author":"TA Lutz","year":"2012","unstructured":"Lutz, T. A. Control of energy homeostasis by amylin. Cell. Mol. Life Sci. 69, 1947\u20131965 (2012).","journal-title":"Cell. Mol. Life Sci."},{"key":"1393_CR5","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1007\/s12325-016-0326-5","volume":"33","author":"K Herrmann","year":"2016","unstructured":"Herrmann, K., Brunell, S. C., Li, Y., Zhou, M. & Maggs, D. G. Impact of disease duration on the effects of pramlintide in type 1 diabetes: a post hoc analysis of three clinical trials. Adv. Ther. 33, 848\u2013861 (2016).","journal-title":"Adv. Ther."},{"key":"1393_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1463-1326.2010.01337.x","volume":"13","author":"D Singh-Franco","year":"2011","unstructured":"Singh-Franco, D., Perez, A. & Harrington, C. The effect of pramlintide acetate on glycemic control and weight in patients with type 2 diabetes mellitus and in obese patients without diabetes: a systematic review and meta-analysis. Diabetes Obes. Metab. 13, 169\u2013180 (2011).","journal-title":"Diabetes Obes. Metab."},{"key":"1393_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1124\/mol.56.1.235","volume":"56","author":"G Christopoulos","year":"1999","unstructured":"Christopoulos, G. et al. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol. Pharmacol. 56, 235\u2013242 (1999).","journal-title":"Mol. Pharmacol."},{"key":"1393_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bph.14075","volume":"175","author":"DL Hay","year":"2018","unstructured":"Hay, D. L., Garelja, M. L., Poyner, D. R. & Walker, C. S. Update on the pharmacology of calcitonin\/CGRP family of peptides: IUPHAR review 25. Br. J. Pharmacol. 175, 3\u201317 (2018).","journal-title":"Br. J. Pharmacol."},{"key":"1393_CR9","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1124\/mol.108.047142","volume":"74","author":"T Qi","year":"2008","unstructured":"Qi, T. et al. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function. Mol. Pharmacol. 74, 1059\u20131071 (2008).","journal-title":"Mol. Pharmacol."},{"key":"1393_CR10","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1124\/mol.105.021915","volume":"69","author":"M Udawela","year":"2006","unstructured":"Udawela, M. et al. Distinct receptor activity-modifying protein domains differentially modulate interaction with calcitonin receptors. Mol. Pharmacol. 69, 1984\u20131989 (2006).","journal-title":"Mol. Pharmacol."},{"key":"1393_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1124\/jpet.121.000567","volume":"377","author":"MM Fletcher","year":"2021","unstructured":"Fletcher, M. M. et al. AM833 is a novel agonist of calcitonin family G protein-coupled receptors: pharmacological comparison with six selective and nonselective agonists. J. Pharmacol. Exp. Ther. 377, 417\u2013440 (2021).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1393_CR12","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/ijo.2009.238","volume":"34","author":"CM Mack","year":"2010","unstructured":"Mack, C. M. et al. Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight. Int J. Obes. 34, 385\u2013395 (2010).","journal-title":"Int J. Obes."},{"key":"1393_CR13","doi-asserted-by":"publisher","first-page":"E598","DOI":"10.1152\/ajpendo.00419.2016","volume":"313","author":"S Gydesen","year":"2017","unstructured":"Gydesen, S. et al. Optimization of tolerability and efficacy of the novel dual amylin and calcitonin receptor agonist KBP-089 through dose escalation and combination with a GLP-1 analog. Am. J. Physiol. Endocrinol. Metab. 313, E598\u2013E607 (2017).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1393_CR14","doi-asserted-by":"publisher","first-page":"A54","DOI":"10.1210\/jendso\/bvab048.108","volume":"5","author":"LM John","year":"2021","unstructured":"John, L. M., Kruse, T. & Raun, K. Preclinical weight loss efficacy of AM833 in combination with semaglutide in rodent models of obesity. J. Endocr. Soc. 5, A54\u2013A54 (2021).","journal-title":"J. Endocr. Soc."},{"key":"1393_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1124\/jpet.119.263392","volume":"374","author":"AT Larsen","year":"2020","unstructured":"Larsen, A. T., Sonne, N., Andreassen, K. V., Karsdal, M. A. & Henriksen, K. The calcitonin receptor plays a major role in glucose regulation as a function of dual amylin and calcitonin receptor agonist therapy. J. Pharmacol. Exp. Ther. 374, 74\u201383 (2020).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1393_CR16","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(21)00845-X","volume":"397","author":"LB Enebo","year":"2021","unstructured":"Enebo, L. B. et al. Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4\u2009mg for weight management: a randomised, controlled, phase 1b trial. Lancet 397, 1736\u20131748 (2021).","journal-title":"Lancet"},{"key":"1393_CR17","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0140-6736(21)00944-2","volume":"397","author":"S Becerril","year":"2021","unstructured":"Becerril, S. & Fr\u00fchbeck, G. Cagrilintide plus semaglutide for obesity management. Lancet 397, 1687\u20131689 (2021).","journal-title":"Lancet"},{"key":"1393_CR18","doi-asserted-by":"publisher","first-page":"eabm9609","DOI":"10.1126\/science.abm9609","volume":"375","author":"J Cao","year":"2022","unstructured":"Cao, J. et al. A structural basis for amylin receptor phenotype. Science 375, eabm9609 (2022).","journal-title":"Science"},{"key":"1393_CR19","doi-asserted-by":"publisher","first-page":"101444","DOI":"10.1016\/j.molmet.2022.101444","volume":"58","author":"L Boccia","year":"2022","unstructured":"Boccia, L. et al. Hypophagia induced by salmon calcitonin, but not by amylin, is partially driven by malaise and is mediated by CGRP neurons. Mol. Metab. 58, 101444 (2022).","journal-title":"Mol. Metab."},{"key":"1393_CR20","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1002\/jbmr.1602","volume":"27","author":"N Binkley","year":"2012","unstructured":"Binkley, N. et al. A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the oral calcitonin in postmenopausal osteoporosis (ORACAL) trial. J. Bone Miner. Res. 27, 1821\u20131829 (2012).","journal-title":"J. Bone Miner. Res."},{"key":"1393_CR21","doi-asserted-by":"publisher","first-page":"11183","DOI":"10.1021\/acs.jmedchem.1c00565","volume":"64","author":"T Kruse","year":"2021","unstructured":"Kruse, T. et al. Development of cagrilintide, a long-acting amylin analogue. J. Med. Chem. 64, 11183\u201311194 (2021).","journal-title":"J. Med. Chem."},{"key":"1393_CR22","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1111\/bph.13496","volume":"173","author":"RL Bower","year":"2016","unstructured":"Bower, R. L. & Hay, D. L. Amylin structure\u2013function relationships and receptor pharmacology: implications for amylin mimetic drug development. Br. J. Pharmacol. 173, 1883\u20131898 (2016).","journal-title":"Br. J. Pharmacol."},{"key":"1393_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fendo.2019.00155","volume":"10","author":"LB Knudsen","year":"2019","unstructured":"Knudsen, L. B. & Lau, J. The discovery and development of liraglutide and semaglutide. Front. Endocrinol. 10, 155 (2019).","journal-title":"Front. Endocrinol."},{"key":"1393_CR24","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.1111\/ejn.15376","volume":"54","author":"S Arrigoni","year":"2021","unstructured":"Arrigoni, S. et al. A selective role for receptor activity-modifying proteins in subchronic action of the amylin selective receptor agonist NN1213 compared with salmon calcitonin on body weight and food intake in male mice. Eur. J. Neurosci. 54, 4863\u20134876 (2021).","journal-title":"Eur. J. Neurosci."},{"key":"1393_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1021\/acsptsci.8b00017","volume":"1","author":"YL Liang","year":"2018","unstructured":"Liang, Y. L. et al. Dominant negative G proteins enhance formation and purification of agonist-GPCR-G protein complexes for structure determination. ACS Pharmacol. Transl. Sci. 1, 12\u201320 (2018).","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"1393_CR26","doi-asserted-by":"publisher","first-page":"5211","DOI":"10.1073\/pnas.1221585110","volume":"110","author":"D Wootten","year":"2013","unstructured":"Wootten, D., Simms, J., Miller, L. J., Christopoulos, A. & Sexton, P. M. Polar transmembrane interactions drive formation of ligand-specific and signal pathway-biased family B G protein-coupled receptor conformations. Proc. Natl Acad. Sci. USA 110, 5211\u20135216 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1393_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28683-0","volume":"13","author":"F Zhao","year":"2022","unstructured":"Zhao, F. et al. Structural insights into multiplexed pharmacological actions of tirzepatide and peptide 20 at the GIP, GLP-1 or glucagon receptors. Nat. Commun. 13, 1057 (2022).","journal-title":"Nat. Commun."},{"key":"1393_CR28","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1021\/acsptsci.9b00089","volume":"3","author":"JJ Gingell","year":"2020","unstructured":"Gingell, J. J. et al. Distinct patterns of internalization of different calcitonin gene-related peptide receptors. ACS Pharmacol. Transl. Sci. 3, 296\u2013304 (2020).","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"1393_CR29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bpj.2020.05.027","volume":"119","author":"K Lam","year":"2020","unstructured":"Lam, K. & Tajkhorshid, E. Membrane interactions of Cy3 and Cy5 fluorophores and their effects on membrane-protein dynamics. Biophys. J. 119, 24\u201334 (2020).","journal-title":"Biophys. J."},{"key":"1393_CR30","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.molcel.2020.09.020","volume":"80","author":"X Zhang","year":"2020","unstructured":"Zhang, X. et al. Differential GLP-1R binding and activation by peptide and non-peptide agonists. Mol. Cell 80, 485\u2013500.e7 (2020).","journal-title":"Mol. Cell"},{"key":"1393_CR31","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nature22327","volume":"546","author":"YL Liang","year":"2017","unstructured":"Liang, Y. L. et al. Phase-plate cryo-EM structure of a class B GPCR-G-protein complex. Nature 546, 118\u2013123 (2017).","journal-title":"Nature"},{"key":"1393_CR32","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1021\/acsptsci.9b00080","volume":"3","author":"YL Liang","year":"2020","unstructured":"Liang, Y. L. et al. Structure and dynamics of adrenomedullin receptors AM1 and AM2 reveal key mechanisms in the control of receptor phenotype by receptor activity-modifying proteins. ACS Pharmacol. Transl. Sci. 3, 263\u2013284 (2020).","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"1393_CR33","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nature10361","volume":"477","author":"SG Rasmussen","year":"2011","unstructured":"Rasmussen, S. G. et al. Crystal structure of the \u03b22 adrenergic receptor\u2013Gs protein complex. Nature 477, 549\u2013555 (2011).","journal-title":"Nature"},{"key":"1393_CR34","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41586-018-0535-y","volume":"561","author":"YL Liang","year":"2018","unstructured":"Liang, Y. L. et al. Cryo-EM structure of the active, Gs-protein complexed, human CGRP receptor. Nature 561, 492\u2013497 (2018).","journal-title":"Nature"},{"key":"1393_CR35","doi-asserted-by":"publisher","first-page":"e42166","DOI":"10.7554\/eLife.42166","volume":"7","author":"J Zivanov","year":"2018","unstructured":"Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. eLife 7, e42166 (2018).","journal-title":"eLife"},{"key":"1393_CR36","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"1393_CR37","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jsb.2015.08.008","volume":"192","author":"A Rohou","year":"2015","unstructured":"Rohou, A. & Grigorieff, N. CTFFIND4: fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216\u2013221 (2015).","journal-title":"J. Struct. Biol."},{"key":"1393_CR38","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"1393_CR39","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/bip.22042","volume":"97","author":"K-Y Chan","year":"2012","unstructured":"Chan, K.-Y., Trabuco, L. G., Schreiner, E. & Schulten, K. Cryo-electron microscopy modeling by the molecular dynamics flexible fitting method. Biopolymers 97, 678\u2013686 (2012).","journal-title":"Biopolymers"},{"key":"1393_CR40","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"1393_CR41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"1393_CR42","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/pro.3330","volume":"27","author":"CJ Williams","year":"2018","unstructured":"Williams, C. J. et al. MolProbity: more and better reference data for improved all-atom structure validation. Protein Sci. 27, 293\u2013315 (2018).","journal-title":"Protein Sci."},{"key":"1393_CR43","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski, R. A. & Swindells, M. B. LigPlot+: multiple ligand\u2013protein interaction diagrams for drug discovery. J. Chem. Inf. Model. 51, 2778\u20132786 (2011).","journal-title":"J. Chem. Inf. Model."},{"key":"1393_CR44","doi-asserted-by":"publisher","first-page":"107702","DOI":"10.1016\/j.jsb.2021.107702","volume":"213","author":"A Punjani","year":"2021","unstructured":"Punjani, A. & Fleet, D. J. 3D variability analysis: resolving continuous flexibility and discrete heterogeneity from single particle cryo-EM. J. Struct. Biol. 213, 107702 (2021).","journal-title":"J. Struct. Biol."},{"key":"1393_CR45","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41589-023-01393-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-023-01393-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-023-01393-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T15:03:32Z","timestamp":1706713412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41589-023-01393-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,3]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1393"],"URL":"https:\/\/doi.org\/10.1038\/s41589-023-01393-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2268316\/v1","asserted-by":"object"}]},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,3]]},"assertion":[{"value":"13 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.M.S. and D.W. are shareholders and P.M.S. is a co-founder of Septerna Inc. P.M.S. and D.W. are co-founders and shareholders of DACRA Therapeutics. H.S., K.L., A.E., G.T., M.B. and Z.L. are current or former employees of Sanofi. All other authors have no competing interests to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}